TGFB1 and cancer: Given the importance of E3 ligases in TGFβ-induced cancer progression, targeting those that are overly active, due to mutation or gene amplification (or overexpressed), in advanced cancer, and those that promote TGFβ signaling in cancer, may work as an alternative, more selective therapeutic strategy.